Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Globocef Healthcare is an Indian pharmaceutical company dedicated to the marketing and distribution of high-quality therapeutic formulations, with a specialized focus on anti-infective medications. The company is prominently known for its range of cephalosporin antibiotics, particularly Cefpodoxime Proxetil, which is marketed under the flagship brand name Globocef. Its product portfolio encompasses a variety of dosage forms, including tablets and oral suspensions, designed to treat common bacterial infections such as those affecting the respiratory and urinary tracts. Operating as a private limited company, Globocef Healthcare leverages a robust distribution network to provide affordable healthcare solutions across the Indian domestic market. The firm is committed to improving patient outcomes by ensuring the availability of essential generic medicines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Globocef.